Putting the Formulation Back in Foam: Optimizing Seborrheic Dermatitis Treatment Across Diverse Hair Types

Raj Chovatiya; Meredith Tyree Polaskey; Edward Lain; Todd Schlesinger; Heather Woolery-Llloyd; Patrick Burnett; Diane Hanna

Putting the Formulation Back in Foam: Optimizing Seborrheic Dermatitis Treatment Across Diverse Hair Types

J Clin Aesthet Dermatol. 2024 May;17(5):30-33.

Authors

Raj Chovatiya^#¹, Meredith Tyree Polaskey^#², Edward Lain³, Todd Schlesinger⁴, Heather Woolery-Llloyd⁵, Patrick Burnett⁶, Diane Hanna⁶

Affiliations

¹ Dr. Chovatiya is a Clinical Associate Professor at the Rosalind Franklin University of Chicago Medical School and is the Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, Illinois.
² Ms. Polaskey is with the Department of Dermatology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.
³ Dr. Lain is with Sanova Dermatology and the Austin Institute for Clinical Research in Austin, Texas.
⁴ Dr. Schlesinger is with the Dermatology and Laser Center of Charleston and Clinical Research Center of the Carolinas in Charleston, South Carolina.
⁵ Dr. Woolery-Llloyd is with Dr. Phillip Frost's Department of Dermatology and Cutaneous Surgery at University of Miami's Miller School of Medicine in Miami, Florida.
⁶ Drs. Hanna and Burnett are with Arcutis Biotherapeutics, Inc. in Westlake Village, California.

^# Contributed equally.

PMID: 38779376
PMCID: PMC11107903

Abstract

Seborrheic dermatitis (SD) is a chronic inflammatory skin condition that commonly involves the scalp, and thus, affects a diverse demographic with varying hair care needs. Current SD treatments are limited based on optimized formulation, efficacy, adverse events, and lack of placebo-controlled trials. A novel roflumilast foam formulation has emerged as a promising therapeutic option optimally designed for use on the scalp and other hair-bearing areas. We conducted a comprehensive assessment of beauty industry standards, confirming the foam formulation's alignment with industry guidelines and exclusion of potentially harmful ingredients. In addition, consultation with an expert dermatologist panel yielded a strong endorsement, underscoring a high level of confidence in prescribing the foam across diverse hair and skin types.

Keywords: Seborrheic dermatitis.

Publication types

Editorial